🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or injecting at residence.

Within minutes of joining one group, a seller shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Item Details and Pricing

Inside these groups, messages show black plastic packages with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.